Innovating Works

ChroWoDoc

Financiado
Mobile Primary Care Device for Documentation and Analysis of Chronic Wounds - Ma...
Mobile Primary Care Device for Documentation and Analysis of Chronic Wounds - Market Transition More than 12 million people worldwide suffer from chronic wounds. These open wounds need to be treated in the long term, resulting in annual costs of €27 billion. The treatment of chronic wounds is based on recurring medical exami... More than 12 million people worldwide suffer from chronic wounds. These open wounds need to be treated in the long term, resulting in annual costs of €27 billion. The treatment of chronic wounds is based on recurring medical examinations at intervals of 4 weeks, which include photographic documentation and a measurement of the wound. According to the current state of the art, this is simply done with a ruler, whereby the ruler is often inserted directly into the wound to assess the depth of the wound. This method not only leads to unreliable and non-reproducible results. It also takes up to 30 min. and is associated with massive pain for patients. To provide patients with relief and efficiently support wound healing, cureVision has developed a unique primary care device that enables fast and accurate documentation and analysis of chronic wounds. Our device contains multiple cameras and detectors that fully automatical analyse seven critical parameters without touching the wound itself. In addition to the wound dimensions, the integrated AI also automatically and reliably analyses the tissue components of the wound (%). Thus, for the first time, our mobile primary care device enables fast and accurate assessment for every wound to enable clinicians to adjust the therapy early. In addition to the significantly more comfortable, non-invasive examination for the patient, our device reduces the examination time by up to 60 %. The optimised therapy will reduce both treatment time and hospitalisation rates, resulting in annual cost savings of over € 40 million in Germany alone. After producing a first working MVP, we now want to produce 50 final MVPs to test and verify the functions under real conditions and make adjustments based on user feedback. Before we go to market, our device must be approved as a medical product. In addition, we will set up a reliable data protection management system. These final steps are to be achieved within the outline of the present project. ver más
29/02/2024
CUREVISION GMBH
75K€
Perfil tecnológico estimado
Duración del proyecto: 8 meses Fecha Inicio: 2023-05-31
Fecha Fin: 2024-02-29

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-02-29
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU
Cerrada hace 2 años
Presupuesto El presupuesto total del proyecto asciende a 75K€
Líder del proyecto
CUREVISION GMBH No se ha especificado una descripción o un objeto social para esta compañía.